KRSNAA Diagnostics IPO: Shares allotment finalisation date, listing date, refund date, minimum bid, lot size, price band and more - TOP 10 details to know – COMPLETE INSIGHT here

KRSNAA Diagnostics Limited IPO – The Initial Public Offering (IPO) of KRSNAA Diagnostics Limited has opened on 4 August (Wednesday). The three-day IPO will end on 6 August. The erstwhile Krsnaa Diagnostics Pvt Ltd company gives in radiology and pathology services.

See Zee Business Live TV Streaming Below:

KRSNAA Diagnostics Limited IPO – Top 10 details  

1. The stock will be listed as KRSNAA Diagnostics Limited with symbol as ‘KRSNAA’  
2. Issue Period is between 4 and 6 August 2021 with market timings from 10 am to 5 pm. 
3. The Issue Size comprises of 12,836,498  
4. The Price Band is Rs 933- Rs 954 with Minimum Bid Quantity of 1 lot of 15 shares. Share price for eligible employees is Rs 93 per equity shares. 
5. Retail investors can subscribe up to Rs 2 lakhs while the eligible employees can subscribe up to Rs 5 lakhs.    
6. Maximum Bid Quantity for Qualified Institutional Investors – 12,598,395 while Non-Institutional Investors it is 3,149,595 shares. 
7. The Book Running Lending Managers (BRLM) are JM Financial Limited, DAM Capital Advisors Limited, Equirus Capital Private Limited and IIFL Securities Ltd. The sponsor bank is ICICI Bank Limited.  
8. The registrar for KRSNAA Diagnostics Limited IPO KFin Technologies Private Limited.  
9. Retail Individual Investors shall have UPI as an additional payment mechanism with Application Supported by Block Amount (ASBA) for making payments.  
10. All Other Category of Investors shall mandatorily use only Application Supported by Blocked Amount (ASBA) facility for making payments.  

KRSNAA Diagnostics Limited IPO – Complete timeline 

Issue ends on 6 August, Friday. 
Finalisation of basis of allotment likely on 12 August 
Initiation of refunds likely on 13 August 
Transfer to demat accounts likely on 16 August 
Listing likely on 17 August  

KRSNAA Diagnostics Limited IPO – What Anil Singhvi recommends  

1. The Market Guru said that the company is relatively smaller against its peers like Dr Lal Path Labs and Metropolis Healthcare.  
2. The company has a different business model, and they are into value added services. This gives them a higher margin and revenue per customer for those services, Singhvi said. 
3. Their track record over the last 8-9 years suggests that the business is growing quite fast. With small size, it is easy to grow more, he added. 
4. The Managing Editor said that the issue has strong anchor book with top investors. The promoters have a small shareholding of 27 per cent. 
5. He said that there are growth opportunities in this company and investors can put money for listing gains and also for long term investment. 

The net proceeds of the Fresh Issue will be utilised in the following manner:  

1. Proposing to finance the cost of establishing diagnostics centres at Punjab, Karnataka, Himachal Pradesh and Maharashtra.  

2. Repayment/pre-payment, in full or part, of certain borrowings availed by our Company; and  

3. General corporate purposes.